# Neuphoria Therapeutics Inc.: Form 8-K, filed Jul 16, 2024

- Company: [Neuphoria Therapeutics Inc.](/companies/neup.md) (CIK 1191070)
- Form: 8-K
- Filed: 2024-07-16
- Accepted by EDGAR: Jul 16, 2024, 10:30 ET
- Period: 2024-07-11
- Accession: 0001213900-24-061529
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1191070/000121390024061529/ea0209330-8k_bionomic.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1191070/000121390024061529/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1191070/000121390024061529/ea0209330-8k_bionomic.htm

Filed Jul 16, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-061529. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.